3M Company (MMM) is eyeing one of the best performances in the Dow Jones in 2024, showing strong trajectory and the potential for purchasing the stock at a significant discount considering its undervalued status. MMM's resilient second-quarter results have led to an updated yearly earnings forecast, which has instigated growth and impressively reduced costs. The
newly appointed CFO, increased
quarterly dividends, and the news of its
Healthcare Business spinning off into Solventum boost positivity among investors. A significant dip in the broader market has not spared MMM, but it has still attracted heavy institutional investors' attention who now own 66% of the company. The company showed
solid operational performance throughout the year, including an impressive Q2 that saw the stock soar. MMM is strategically progressing, with the
spin-off completion of Solventum marking a significant milestone. A slight market rise saw the MMM stock slide, but the stock recovered. The company is still seen by many as a good investment, with optimistic investors driving the share price up. A cut in dividends didn't deter investors as 3M led gains on the Dow after an upgrade from BofA.
3m Company MMM News Analytics from Thu, 16 Nov 2023 08:00:00 GMT to Sat, 28 Sep 2024 15:43:39 GMT -
Rating 8
- Innovation 6
- Information 8
- Rumor -4
